SCHEMBL2407988

SCHEMBL2407988

Clc1nc(-c2cccc(Cc3ccccc3)n2)nc2sccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 6/20 0.43
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 2/20 0.36
PKM P14618 2/20 0.36
ADORA1 P30542 3/20 0.36
METAP1 P53582 1/20 0.35
HTR2C P28335 1/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
CASP3 P42574 1/20 0.34
RAB9A P51151 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
BRD4 O60885 1/20 0.34
PDE4B Q07343 1/20 0.33
USP1 O94782 1/20 0.33
WDR48 Q8TAF3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2414877 0.82 KMT2A (0.39) ADORA2AALDH1A1SMN1; SMN2MAPTPKM
SCHEMBL2409139 0.81 PDE4A (0.41) ADORA2AALDH1A1SMN1; SMN2PKMMETAP1
SCHEMBL2409883 0.80 KMT2A (0.38) ADORA2AALDH1A1SMN1; SMN2MAPTPKM
SCHEMBL2413283 0.77 BRD4 (0.35) ADORA2AALDH1A1SMN1; SMN2MAPTPKM
SCHEMBL31045060 0.74 METAP1 (0.59) ADORA2ASMN1; SMN2ADORA1METAP1HTR2C
SCHEMBL14112790 0.74 METAP1 (0.59) ADORA2ASMN1; SMN2ADORA1METAP1HTR2C
SCHEMBL2408334 0.73 KRAS (0.60) ALDH1A1SMN1; SMN2MAPTPKMNPC1
SCHEMBL9026739 0.69 KDM4E (0.46) ADORA2AALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL9027654 0.69 BRD4 (0.45) ADORA2AALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL2414783 0.68 BRD4 (0.35) ADORA2AALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2539338-A1 NOVEL MICROBICIDES Syngenta Participations AG (CH) 2013-01-02 EP disclosed
US-20120316184-A1 NOVEL MICROBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-12-13 US disclosed
CN-102770433-A Novel microbicides SYNGENTA PARTICIPATIONS A G 2012-11-07 CN disclosed
WO-2011104183-A1 NOVEL MICROBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2011-09-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120316184-A1 NOVEL MICROBICIDES NOX1, MSR1, FPR1 ADORA2A 1826/4885ALDH1A1 116/4885SMN1; SMN2 3707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.